Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 11.55M P/E - EPS this Y 18.10% Ern Qtrly Grth -
Income -18.08M Forward P/E -0.77 EPS next Y 38.40% 50D Avg Chg -1.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -8.00%
Dividend N/A Price/Book 0.43 EPS next 5Y - 52W High Chg -53.00%
Recommedations 2.00 Quick Ratio 1.05 Shares Outstanding 14.40M 52W Low Chg 20.00%
Insider Own 1.10% ROA -64.75% Shares Float 13.69M Beta 2.13
Inst Own 11.06% ROE -143.19% Shares Shorted/Prior 473.56K/387.84K Price 1.27
Gross Margin - Profit Margin - Avg. Volume 30,024 Target Price 14.20
Oper. Margin - Earnings Date Nov 12 Volume 17,513 Change 0.79%
About Imunon, Inc.

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.

Imunon, Inc. News
11/11/24 IMNN: Meeting with FDA in Preparation for Phase 3 Ovarian Cancer Trial
11/08/24 Imunon Inc (IMNN) Q3 2024 Earnings Call Highlights: Promising Clinical Advances Amid Financial ...
11/07/24 IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual Meeting
11/07/24 IMUNON Reports Third Quarter 2024 Financial Results and Provides Business Updates
10/31/24 IMUNON to Hold Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 7, 2024
10/30/24 IMUNON to Present Phase 2 Data of IMNN-001 in Treatment of Newly Diagnosed Ovarian Cancer at SITC 39th Annual Meeting
10/08/24 Imunon reports inducement grant under NASDAQ listing rule
10/07/24 IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
09/09/24 UPDATE - IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management
09/09/24 IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management
08/28/24 IMUNON to Host R&D Day on September 18th
08/15/24 IMNN: Positive Results for OVATION 2 Trial Supports Advancing IMNN-001 Into Phase 3 Study…
08/14/24 IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update
08/07/24 IMUNON to Hold Second Quarter 2024 Financial Results and Business Update Conference Call on Wednesday, August 14, 2024
07/31/24 Imunon’s shares soar after IL-12 therapy success in Phase II trial
07/31/24 IMUNON Announces $10 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
07/30/24 Sector Update: Health Care Stocks Edge Higher Late Afternoon
07/30/24 Top Midday Gainers
07/30/24 IMUNON Announces 11.1 Month Increase in Overall Survival in Patients with Newly Diagnosed, Advanced Ovarian Cancer Treated with IMNN-001
07/29/24 IMUNON to Report Topline Results from the Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer Tomorrow
IMNN Chatroom

User Image FlashingTrends Posted - 19 hours ago

$ABVE It's an Ai play as well but very cheap with huge upside. High was at 13.50, now we are at .68 cent. Gapping Monday. ABVE ✔️ ✅️ 🚀 #6 TRENDING. $GFAI Ai also $RGTI looks good $IMNN just found this.

User Image funnymoney90210 Posted - 1 day ago

$IMNN lets gooooooo. No Diddy.😂

User Image Jacks10 Posted - 2 days ago

$IMNN another leg higher, let's go!

User Image PharmaExpert Posted - 2 days ago

$AKBA, $VRPX, $IMNN, $AGEN, $HSDT 🔥🔥🔥🔥🔥

User Image FearLesSTradeRx Posted - 2 days ago

$MDAI $LASE $IMNN Swang N Bang 🔐‼️ #NoFear 😈 #GlobalMoneyTraders ♻️ #GMT 💯

User Image jai105 Posted - 2 days ago

$IMNN https://www.nasdaq.com/market-activity/stocks/clsn/institutional-holdings sabby is here

User Image magicmike375 Posted - 2 days ago

$IMNN Damit all there goes my big order at 0.50

User Image I_AM_GROOT Posted - 2 days ago

$IMNN what tha hell? A green candle.. I call BS. 52 week low on deck.

User Image pablo4 Posted - 3 days ago

$IMNN if you're a technical trader, you want to buy here, IMO. They have sufficient cash for a year, good science and the RSI is extremely, extremely oversold at 22. Anyone grabbing here should at least get a nice bounce trade out of this. JMO

User Image Mac1962 Posted - 4 days ago

$CLN back in at 2.56, daddy need a new barn...

User Image TheManUpstairs Posted - 4 days ago

$IMNN has approx 14 mega in cash right now, but they will need 50 mega for the PHASE 3 of IMNN-001 ... how to solve this problem?

User Image funnymoney90210 Posted - 4 days ago

$IMNN

User Image magicmike375 Posted - 4 days ago

$IMNN come on down you’re the next contestant on the prices, right

User Image Rainsjd Posted - 6 days ago

$IMNN Welcome to the casino! Unfortunately, it appears you lose again. But please, don’t give up! ATM’s right over there against the wall.

User Image funnymoney90210 Posted - 1 week ago

$IMNN going to $3

User Image magicmike375 Posted - 1 week ago

$IMNN don’t be surprised if there is a buy out just sayin

User Image I_AM_GROOT Posted - 1 week ago

$IMNN .20 buy target. They have no defemse for shorty attack. Zero

User Image Scoty_D Posted - 1 week ago

$IMNN CLSN 4 life!

User Image Zit1343 Posted - 1 week ago

$IMNN we might see 0.69 or even 0.66

User Image funnymoney90210 Posted - 1 week ago

$IMNN

User Image I_AM_GROOT Posted - 1 week ago

$IMNN Seems HC Wainwright's credibility is shit. "HC Wainwright lowered their price target on shares of Imunon from $14.00 to $12.00 and set a “buy” rating for the company in a report on Monday." Lol just follow them and short = ez money.

User Image koulio62 Posted - 1 week ago

$IMNN Was wondering if anyone read the recent update …. NEWS….

User Image I_AM_GROOT Posted - 1 week ago

$IMNN manipulation here is insane.

User Image bobbythek Posted - 1 week ago

$IMNN For those who chided me when i told you to get out when it spiked to over 3 bucks, sorry you did not listen. company a disaster for over a decade. I learned the hard way...

User Image koulio62 Posted - 2 weeks ago

$IMNN Can’t wait for this bleeding to stop….

User Image koulio62 Posted - 2 weeks ago

$IMNN How can you have great results and the price tank???

User Image koulio62 Posted - 2 weeks ago

$IMNN

User Image _SPYtraderPro_ Posted - 2 weeks ago

$IMNN

User Image Coolio7690 Posted - 2 weeks ago

$IMNN reversal from here

User Image magicmike375 Posted - 2 weeks ago

$IMNN i got back in let’s see

Analyst Ratings
EF Hutton Buy Sep 23, 24
HC Wainwright & Co. Buy Aug 15, 24
HC Wainwright & Co. Buy Aug 5, 24
HC Wainwright & Co. Buy May 14, 24
HC Wainwright & Co. Buy Apr 1, 24
HC Wainwright & Co. Buy Mar 13, 24
HC Wainwright & Co. Buy Sep 15, 23
HC Wainwright & Co. Buy Aug 11, 23
HC Wainwright & Co. Buy May 12, 23